Cargando…
243P CDK4/6 inhibitors in clinical practice during COVID-19 pandemic: Comparative analysis of the clinical impact of the pandemic for metastatic breast cancer patients during first and second waves in the UK
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454310/ http://dx.doi.org/10.1016/j.annonc.2021.08.526 |
| _version_ | 1784570459135672320 |
|---|---|
| author | Fouda, M.M. Kuriakose, V. |
| author_facet | Fouda, M.M. Kuriakose, V. |
| author_sort | Fouda, M.M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8454310 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84543102021-09-21 243P CDK4/6 inhibitors in clinical practice during COVID-19 pandemic: Comparative analysis of the clinical impact of the pandemic for metastatic breast cancer patients during first and second waves in the UK Fouda, M.M. Kuriakose, V. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2021-09 2021-09-21 /pmc/articles/PMC8454310/ http://dx.doi.org/10.1016/j.annonc.2021.08.526 Text en Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Fouda, M.M. Kuriakose, V. 243P CDK4/6 inhibitors in clinical practice during COVID-19 pandemic: Comparative analysis of the clinical impact of the pandemic for metastatic breast cancer patients during first and second waves in the UK |
| title | 243P CDK4/6 inhibitors in clinical practice during COVID-19 pandemic: Comparative analysis of the clinical impact of the pandemic for metastatic breast cancer patients during first and second waves in the UK |
| title_full | 243P CDK4/6 inhibitors in clinical practice during COVID-19 pandemic: Comparative analysis of the clinical impact of the pandemic for metastatic breast cancer patients during first and second waves in the UK |
| title_fullStr | 243P CDK4/6 inhibitors in clinical practice during COVID-19 pandemic: Comparative analysis of the clinical impact of the pandemic for metastatic breast cancer patients during first and second waves in the UK |
| title_full_unstemmed | 243P CDK4/6 inhibitors in clinical practice during COVID-19 pandemic: Comparative analysis of the clinical impact of the pandemic for metastatic breast cancer patients during first and second waves in the UK |
| title_short | 243P CDK4/6 inhibitors in clinical practice during COVID-19 pandemic: Comparative analysis of the clinical impact of the pandemic for metastatic breast cancer patients during first and second waves in the UK |
| title_sort | 243p cdk4/6 inhibitors in clinical practice during covid-19 pandemic: comparative analysis of the clinical impact of the pandemic for metastatic breast cancer patients during first and second waves in the uk |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454310/ http://dx.doi.org/10.1016/j.annonc.2021.08.526 |
| work_keys_str_mv | AT foudamm 243pcdk46inhibitorsinclinicalpracticeduringcovid19pandemiccomparativeanalysisoftheclinicalimpactofthepandemicformetastaticbreastcancerpatientsduringfirstandsecondwavesintheuk AT kuriakosev 243pcdk46inhibitorsinclinicalpracticeduringcovid19pandemiccomparativeanalysisoftheclinicalimpactofthepandemicformetastaticbreastcancerpatientsduringfirstandsecondwavesintheuk |